Wealth Enhancement Advisory Services, LLC Dr Reddys Laboratories LTD Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,909 shares of RDY stock, worth $204,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,909
Previous 13,026
6.78%
Holding current value
$204,740
Previous $205,000
10.73%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$158 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$135 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$133 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$129 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$91.3 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.44B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...